// App-Quantinova.ai

TCT-10 : Mechanisms of Very Late Bioresorbable Scaffold Thrombosis Assessed by Optical Coherence Tomography: Insights from the international INVEST registry

Researchers

Presenter

  • Kyohei Yamaji

Principal Investigators

  • Geraud Souteyrand

  • Joost Daemen

  • Robert Byrne

  • Jens Wiebe

  • Petra Hoppmann

  • Holger Nef

  • Niklas Boeder

  • Tom Adriaenssens

  • Joshua Loh

  • Benoit Lattuca

  • Joanna Wykrzykowska

  • Josep Gomez Lara

  • Leo Timmers

  • Mohamed Abdel-Wahab

  • Felix Meincke

  • Benjamin Honton

  • Crochan O'Sullivan

  • Alfonso Ielasi

  • Gunter Christ

  • Joe Lee

  • Michael Lee

  • Nicolas Amabile

  • Alexios Karagiannis

  • Stephan Windecker

  • Lorenz Raber

Medical Centers

  • Heart Center, Segeberger Kliniken, Bad Segeberg, Germany

  • Asklepios Klinik St. Georg, Hamburg, Germany

  • Academic Medical Center, Amsterdam, Netherlands

  • Toulouse, France

  • University Hospital of Bern, Bern, Switzerland

  • Queen Elizabeth Hospital, Hong Kong, Hong Kong, China

  • CTU Bern, and Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland

  • Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong

  • Imm, Paris, France

  • Department of Cardiology, University of Giessen, Germany, Giessen, Germany

  • Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

  • Inselspital, Bern, Germany

  • Caremeau, Nîmes, France

  • University Medical Center Utrecht, Utrecht, Netherlands

  • Kokura Memorial Hospital, Japan, Japan

  • Erasmus MC - Thoraxcenter, United States

  • University of Giessen, Giessen, Germany

  • Hospital Universitari de Bellvitge, Hospitalet De Llobregat, Spain

  • Kaiser Franz Josef Hospital, Vienna, Austria

  • Ospedale Bolognini, Seriate, Bergamo, Italy

  • Deutsches Herzzentrum Munchen, Technische Universitat Munchen, Munich, Germany

  • The National University Heart Centre, Singapore, Singapore, Singapore

  • UNIVERSITY HOSPITALS LEUVEN, Leuven, Belgium

  • Clermont-Ferrand University Hospital, Clermont-Ferrand, France

Locations

  • Germany

  • Switzerland

  • United States

  • France

  • Austria

  • Singapore

  • China

  • Netherlands

  • Italy

  • Belgium

  • Japan

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved